CSRG HAQ-DI minimal important difference (MID) estimates for patient-reported outcomes stratified by subset of limited and diffuse SSc.
| Limited | Diffuse | |||||
|---|---|---|---|---|---|---|
| Patient-reported Outcome | Mean MID (SD) in “Somewhat better” Subgroup | Mean (SD) Change in “Same” Subgroup | Mean (SD) MID in “Somewhat worse” Subgroup | Mean MID (SD) in “Somewhat better” Subgroup | Mean (SD) Change in “Same” Subgroup | Mean (SD) MID in “Somewhat worse” Subgroup |
| HAQ-DI* | –0.022/0.250 (0.366) (n = 24) | –0.025/0.125 (0.292) (n = 100) | 0.102/0.375 (0.391) (n = 49) | –0.057/0.250 (0.454) (n = 22) | 0.032/0.125 (0.417) (n = 66) | 0.207/0.500 (0.333) (n = 35) |
↵* Presented as mean change/75th percentile (SD). CSRG: Canadian Scleroderma Research Group; HAQ-DI: Health Assessment Questionnaire-Disability Index.